Other names: Xadago®
Categories: Prescription Medication
Description:
Safinamide (Xadago®) is a MAO-B inhibitor used as an add-on to levodopa in Parkinson’s disease, especially for patients with motor fluctuations or “off” episodes. It works by both inhibiting dopamine breakdown and modulating glutamate release, which may provide added benefit compared to older MAO-B inhibitors. Safinamide can help improve motor control and daily function, making levodopa’s effects last longer. Common side effects include dyskinesia, nausea, insomnia, and headache, though it is usually well tolerated. Its dual mechanism makes it a valuable option for patients needing more stable symptom control.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment 'Safinamide' against 'Parkinson's Disease'. Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment from the given data. More user feedback and clinical studies would be needed to assess the efficacy of Safinamide in managing Parkinson's Disease symptoms.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
